292 related articles for article (PubMed ID: 19686242)
1. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.
Björklund T; Hall H; Breysse N; Soneson C; Carlsson T; Mandel RJ; Carta M; Kirik D
J Neurochem; 2009 Oct; 111(2):355-67. PubMed ID: 19686242
[TBL] [Abstract][Full Text] [Related]
2. Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
Carlsson T; Winkler C; Burger C; Muzyczka N; Mandel RJ; Cenci A; Björklund A; Kirik D
Brain; 2005 Mar; 128(Pt 3):559-69. PubMed ID: 15659429
[TBL] [Abstract][Full Text] [Related]
3. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
[TBL] [Abstract][Full Text] [Related]
4. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
[TBL] [Abstract][Full Text] [Related]
5. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
[TBL] [Abstract][Full Text] [Related]
6. Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.
Cederfjäll E; Sahin G; Kirik D; Björklund T
Mol Ther; 2012 Jul; 20(7):1315-26. PubMed ID: 22294150
[TBL] [Abstract][Full Text] [Related]
7. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
Furukawa Y
Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
[TBL] [Abstract][Full Text] [Related]
8. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.
Lu L; Zhao C; Liu Y; Sun X; Duan C; Ji M; Zhao H; Xu Q; Yang H
Brain Res Brain Res Protoc; 2005 May; 15(1):46-51. PubMed ID: 15878150
[TBL] [Abstract][Full Text] [Related]
11. [Gene therapy for Parkinson's disease: studies in animal models].
Muramatsu S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825
[TBL] [Abstract][Full Text] [Related]
12. Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease.
Rosenblad C; Li Q; Pioli EY; Dovero S; Antunes AS; Agúndez L; Bardelli M; Linden RM; Henckaerts E; Björklund A; Bezard E; Björklund T
Brain; 2019 Aug; 142(8):2402-2416. PubMed ID: 31243443
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
Fan D; Shen Y; Kang D; Nakano I; Ozawa K
Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
[TBL] [Abstract][Full Text] [Related]
14. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.
Mandel RJ; Rendahl KG; Spratt SK; Snyder RO; Cohen LK; Leff SE
J Neurosci; 1998 Jun; 18(11):4271-84. PubMed ID: 9592104
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
16. A site-specific mutation of tyrosine hydroxylase reduces feedback inhibition by dopamine in genetically modified cells grafted in parkinsonian rats.
Chang JW; Lee WY; Milstien S; Kang UJ
J Neurochem; 2002 Oct; 83(1):141-9. PubMed ID: 12358737
[TBL] [Abstract][Full Text] [Related]
17. The assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PD.
Duan CL; Su Y; Zhao CL; Lu LL; Xu QY; Yang H
Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):37-43. PubMed ID: 16338639
[TBL] [Abstract][Full Text] [Related]
18. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
19. Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer.
Kirik D; Georgievska B; Burger C; Winkler C; Muzyczka N; Mandel RJ; Bjorklund A
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4708-13. PubMed ID: 11917105
[TBL] [Abstract][Full Text] [Related]
20. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
